Comparison of six-year clinical outcome of sirolimus-and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: An analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus Stent Evaluated at Rotterdam Cardiology Hospital) registries

Journal of Invasive Cardiology

Volumn 23, Issue 8, 2011, Pages 336-341

  Simsek, Cihan ^a   Magro, Michael ^a   Boersma, Eric ^a   Onuma, Yoshinobu ^a   Nauta, Sjoerd ^a   Daemen, Joost ^a   Gaspersz, Marcia ^a   Van Geuns, Robert Jan ^a   Van Der Giessen, Willem ^a   Van Domburg, Ron ^a   Serruys, Patrick ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

percutaneous coronary intervention; ST segment elevation myocardial infarction; stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; ADVERSE OUTCOME; ARTICLE; BARE METAL STENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL SIGNIFICANCE; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PACLITAXEL; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 80051982078     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Spaulding C, Henry P, Teiger E, et al., for the TYPHOON investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104. (Pubitemid 44394916)
2. Laarman GJ, Suttory MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113. (Pubitemid 44394917)
3. Kukreja N, Onuma Y, Garcia-Garcia H, et al. Primary percutaneous coronary intervention for acute myocardial infarction: Long-term outcome after bare-metal and drug-eluting stent implantation. Circ Cardiovasc Interv 2008;1:103-110.
4. Daemen J, Kukreja N, van Twisk PH, et al. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry. Am J Cardiol 2008;101:1105-1111.
5. Daemen J, Tsuchida K, Stefanini GG, et al. Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. EuroIntervention 2006;2:330-337.
6. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521. (Pubitemid 39410418)
7. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130. (Pubitemid 40617065)
8. Lagerqvist B, James SK, Stenestrand U, et al., for the SCAAR Study Group. Longterm outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. (Pubitemid 46376801)
9. Kernis SJ, Cohen D, Rein K. Clinical outcome associated with use of drug-eluting stents compared with bare-metal stent for primary percutaneous intervention. Am J Cardiol 2005;96(Suppl 7A):47H.
10. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement results from the PREMIER registry. Circulation 2006;113:2803-2809. (Pubitemid 44305292)
11. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678. (Pubitemid 46281313)
12. Piscione F, Piccolo R, Cassese S, et al. Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A meta-analysis of randomized trials and an adjusted indirect comparison. EuroIntervention 2010;5:853-860.
13. Daemen J, Tanimoto S, Garcia-Garcia HM, et al. Comparison of three-year clinical outcome of sirolimus-and paclitaxel-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007;99:1027-1032. (Pubitemid 46560473)
14. Kukreja N, Onuma Y, Garcia-Garcia H, et al. Primary percutaneous coronary intervention for acute myocardial infarction. Long-term outcome after bare-metal and drug-eluting stent implantation. Circ Cardiovasc Interv 2008;1:103-110.
15. Lemos PA, Saia F, Hofma SH, et al. Short-and long-term clinical benefit of sirolimuseluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708. (Pubitemid 38229548)
16. Hofma SH, Ong AT, Aoki J, et al. One-year clinical follow-up of paclitaxel-eluting stents for acute myocardial infarction compared with sirolimus-eluting stents. Heart 2005;91:1176-1180. (Pubitemid 41192393)
17. Daemen J, Tanimoto S, Garcia-Garcia HM, et al. Comparison of three-year clinical outcome of sirolimus-and paclitaxel-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007;99:1027-1032. (Pubitemid 46560473)
18. Simsek C, Onuma Y, Magro M, et al. Interventional Cardiologists of the Thoraxcenter (2000-2005). Four-year clinical outcome of sirolimus-and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheter Cardiovasc Interv 2010;76:41-49.
19. Wohrle J, Desaga M, Metzger C, et al. Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI trial). Am J Cardiol 2010;106:1218-1224.
20. Di Lorenzo E, De Luca G, Sauro R, et al. The PASEO (paclitaxel-or sirolimus-eluting stent versus bare-metal stent in primary angioplasty) randomized trial. J Am Coll Cardiol Interv 2009;2:515-523.
21. Atary JZ, van der Hoeven BL, Liem SS, et al. Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study). Am J Cardiol 2010;106:4-12.
22. Violini R, Musto C, De Felice F, et al. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. J Am Coll Cardiol 2010;55:810-814.
23. Lee JH, Kim HS, Lee SW, et al. Prospective randomized comparison of sirolimus-versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial. Catheter Cardiovasc Interv 2008;72:25-32.
24. Kukreja N, Onuma Y, Garcia-Garcia HM, et al. Primary percutaneous coronary intervention for acute myocardial infarction: Long-term outcome after bare-metal and drug-eluting stent implantation. Circ Cardiovasc Interv 2008;1:103-110.
25. Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-1342.
26. Doyle B, Rihal CS, O'Sullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007;116:2391-2398. (Pubitemid 350145074)